André van Puijenbroek

Health Technology

Consumer Services

Profile

André van Puijenbroek is Manager of Research and Development for InteRNA Technologies BV.
Prior to joining InteRNA Technologies, he was a Group Leader of Organon BioSciences, Inc. for Immunology from 2002 to 2005 and for Oncology from 2005-2008 .
He joined InteRNA Technologies as Project Manager of Research and Development in November 2008.
Prior to it, he worked as a Post-Doctoral Research Fellow Member at the Netherlands Cancer Institute from 1997 to 1999 and the Dana-Farber Cancer Institute at Harvard Medical School from 1999 to 2002.
Dr. van Puijenbroek received an MSc degree in Biology in 1992 and a PhD in Molecular Biology in 1997 from Utrecht University.

Former positions of André van Puijenbroek

Companies	Position	End
Organon Biosciences, Inc.	Corporate Officer/Principal	2004-12-31
InteRNA Technologies BV InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.	Chief Tech/Sci/R&D Officer	-

See the detail of André van Puijenbroek's experience

Training of André van Puijenbroek

University of Utrecht

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of André van Puijenbroek's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
InteRNA Technologies BV InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.	Health Technology
Organon Biosciences, Inc.